Ruga Corporation
 

Targeting Tumor-Selective Adaptive Response

 
Ruga Corporation

 

Ruga Corporation is an innovative private biopharmaceutical company that discovers and develops novel targeted therapeutics in oncology – focusing on targeting tumor genetics for precision treatment of cancer patients. Ruga is dedicated to bringing fundamental biological insights to the clinic, addressing major unmet clinical needs in order to transform personalized oncology therapeutics and enhance the lives of cancer patients.

Our website is currently under construction. We are in the process of adding new information and addtional enhancements. Please come visit us again soon.

 

 

info@rugacorp.com • phone: • fax: •   © 2013, Ruga Corporation